Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome

Free Radical Research

Volumn 41, Issue 3, 2007, Pages 282-287

  Vibo, Riina ^a   Kõrv, Janika ^a   Roose, Mai ^a   Kampus, Priit ^a   Muda, Piibe ^a   Zilmer, Kersti ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Lipoprotein; Oxidative stress; oxLDL; Stroke

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTION; PROTEIN BLOOD LEVEL; RATING SCALE; RISK FACTOR; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BRAIN; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 33947127602     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760601083235     Document Type: Article

References (29)

1. Alexandrova, ML and Bochev, PG (2005) Oxidative stress during the chronic phase after stroke. Free Radic Biol Med, 39, pp. 297-316.
2. Lindsberg, PJ and Grau, AJ (2003) Inflammation and infections as risk factor for ischemic stroke. Stroke, 34, pp. 2518-2532.
3. Paoletti, R., Gotto, AM and Hajjar, DP (2004) Inflammation in atherosclerosis and implications for therapy. Circulation, 109, pp. 20-26.
4. Lobbes, MBI, Lutgens, E., Heeneman, S., Cleutjens, KBJM, Kooi, ME, van Engelshoven, JMA, Daeman, MJAP and Nelemans, PJ (2006) Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidised low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis, 187, pp. 18-25.
5. Uno, M., Kitazato, KT, Nishi, K., Itabe, H. and Nagahiro, S. (2003) Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry, 74, pp. 312-316.
6. Cherubini, A., Ruggiero, C., Polidori, MC and Mecocci, P. (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med, 39, pp. 841-852.
7. Ceaser, EK, Ramachandran, A., Levonen, A-L and Darley-Usmar, VM (2003) Oxidized low-density lipoprotein and 15-deoxy-Δ 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells. Am J Physiol Heart Circ Physiol, 285, pp. 2298-2308.
8. Sastre, J., Pallardo, FV, de la Asuncion, J Garcia and Vina, J. (2000) Mitochondria, oxidative stress and aging. Free Radic Res, 32, pp. 189-198.
9. Ryglewicz, D., Rodo, M. and Roszczynco, M. (2002) Dynamics of LDL oxidation in ischemic stroke patients. Acta Neurol Scand, 105, pp. 185-188.
10. Polidori, MC (1998) Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med, 25, pp. 561-567.
11. ElKossi, MMH and Zakhary, MM (2000) Oxidative stress in the context of acute cerebrovascular stroke. Stroke, 31, pp. 1889-1892.
12. Uno, M., Harada, M. and Takimoto, O. (2005) Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurol Res, 27, pp. 94-102.
13. Shie, F-S, Neely, MD and Maezawa, I. (2004) Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am J Pathol, 164, pp. 1173-1181.
14. Faviou, E., Vourli, G., Nounopoulos, C., Zachari, A. and Dionyssiou-Asteriou, A. (2005) Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease. Free Radic Res, 39, pp. 419-429.
15. Uno, M., Kitazato, KT, Suzue, A., Matsuzaki, K., Harada, M., Itabe, H. and Nagahiro, S. (2005) Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction. Free Radic Biol Med, 39, pp. 1109-1116.
16. Hulthe, J. and Fagerberg, B. (2002) Circulating oxidised LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol, 22, pp. 1162-1167.
17. Masotti, L., Ceccarelli, E., Forconi, S. and Cappelli, R. (2005) Prognostic role of C-reactive protein in very old patients with acute ischemic stroke. J Int Med, 258, pp. 145-152.
18. Rost, NS, Wolf, PA and Kase, CS (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham Study. Stroke, 32, pp. 2575-2579.
19. Adams, HP, Bendixen, BH and Kappelle, LJ (1993) Classification of subtype of acute ischemic stroke. Definitions for use in multicenter clinical trial. Stroke, 24, pp. 35-41.
20. Barber, M., Fail, M., Shields, M., Stott, DJ and Langhorne, P. (2004) Validity and reliability of estimating the Scandinavian Stroke Scale from medical records. Cerebrovasc Dis, 17, pp. 224-227.
21. Wade, DT and Hewer, R Langton (1987) Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry, 50, pp. 177-182.
22. Holvoet, P., Theilmeier, G., Shivalkar, B., Flameng, W. and Collen, D. (1998) LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol, 18, pp. 415-422.
23. Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. and Collen, D. (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 98, pp. 1487-1494.
24. Vibo, R., Körv, J. and Roose, M. (2005) The third stroke registry in Tartu, Estonia: Decline of stroke incidence and 28-day case-fatality rate since 1991. Stroke, 36, pp. 2544-2548.
25. Sánchez-Moreno, C., Dashe, JF, Scott, T., Thaler, D., Folstein, MF and Martin, A. (2004) Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke, 35, pp. 163-168.
26. DiNapoli, M., Papa, F. and Bocola, V. (2001) Prognostive influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke, 32, pp. 133-138.
27. Drouet, L. (1996) Fibrinogen-a treatable risk factor?. Cerebrovasc Dis, 6, pp. 2-6.
28. Weir, CJ, Sattar, N., Walters, MR and Lees, KR (2003) Low triglyceride, not low cholesterol concentration independently predicts poor outcome following acute stroke. Cerebrovasc Dis, 16, pp. 76-82.
29. Dziedzic, T., Slowik, A., Gryz, EA and Szczudlik, A. (2004) Lower serum triglyceride level is associated with increased stroke severity. Stroke, 35, pp. e151-e152.